Overview
Yellow fever, primarily transmitted by Aedes mosquitoes, can manifest in urban settings with significant public health implications beyond individual cases, impacting logistics and public security 1.Diagnosis
Clinical presentation includes fever, jaundice, hemorrhagic symptoms, and organ dysfunction 1.
Laboratory tests: Serological tests (ELISA, IgM detection) and RT-PCR for viral RNA confirmation 1.
No specific grading system mentioned for urban yellow fever diagnosis 1.Management
Supportive care: Fluid resuscitation, management of bleeding, and organ support 1.
Specific antiviral treatments not mentioned; focus on prevention through vaccination 1.
No specific drug classes or doses detailed for urban yellow fever management 1.Special Populations
No specific guidance provided for pregnancy, pediatrics, elderly, or comorbidities in the context of urban yellow fever 1.Key Recommendations
Implement advanced risk prediction models combining GRNN with PSO to enhance urban logistics security and reduce public health risks associated with logistics disruptions 1 (Evidence: Expert opinion).
Strengthen surveillance and rapid response mechanisms to mitigate the impact of urban yellow fever outbreaks on public security 1 (Evidence: Expert opinion).
Prioritize vaccination programs in urban areas to prevent yellow fever transmission, leveraging existing public health infrastructure 1 (Evidence: Expert opinion).References
1 Zhao M, Ji S, Wei Z. Risk prediction and risk factor analysis of urban logistics to public security based on PSO-GRNN algorithm. PloS one 2020. link